Golden State Medical Supply Inc., based in Camarillo, California, has received a $10.3 million modification, extending its contract for an additional year. The contract is for the supply of duloxetine hydrochloride delayed release capsules, with the work to be completed in Spain by September 16, 2024. Various U.S. military branches, the Department of Veterans Affairs, and other federal agencies will utilize the product. The Defense Logistics Agency Troop Support in Philadelphia oversees the contract.
Key Points:
- Golden State Medical Supply Inc. is awarded a $10.3 million contract extension to supply duloxetine hydrochloride delayed release capsules.
- The modified contract extends for one year, marking the third optional year of a potential five-year deal.
- The performance location is set in Spain with a completion date of September 16, 2024.
- The capsules are intended for various entities, including all U.S. military branches, the Department of Veterans Affairs, Indian Health Services, and the Federal Bureau of Prisons.
- The contract is supervised by the Defense Logistics Agency Troop Support in Philadelphia.
